Novel gels and their dispersions - Oral drug delivery systems for ciclosporin

International Journal of Pharmaceutics

Volumn 300, Issue 1-2, 2005, Pages 113-124

  Murdan, Sudaxshina ^a   Andrýsek, Tomas ^b   Son, Delphine ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b R and D Divission   (Czech Republic)

Author keywords

Absorption; Aqueous dispersions; Ciclosporin; Drug delivery; Gels; Oral

Indexed keywords

ALCOHOL; AMPHOPHILE; CYCLOSPORIN A; GELLING AGENT; GLYCEROL OLEATE; HYDROGENATED CASTOR OIL; NONIONIC SURFACTANT; OLEYL ALCOHOL; POLYGLYCERYL 10 OLEATE; POLYGLYCERYL 3 OLEATE; POLYSORBATE 20; POLYSORBATE 80; SORBITAN OLEATE; SORBITAN STEARATE; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DISPERSION; DOG; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; GEL; HYDROPHILICITY; HYDROPHOBICITY; MALE; NONHUMAN; PRIORITY JOURNAL;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; CYCLOSPORINE; DOGS; DRUG DELIVERY SYSTEMS; EMULSIONS; GELS; MALE; PARTICLE SIZE;

EID: 23444460408     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.06.002     Document Type: Article

References (25)

1. T. Andrýsek The role of particle size distribution on bioavailability of ciclosporin: novel drug delivery system Biomed. Pap. 145 2001 3 8
2. ®, novel drug delivery system with cyclosporin Proceedings of the 30th Annual CRS Meeting Glasgow 2003 210
3. P.F. Augustijns, T.P. Bradshaw, L.S. Gan, R.W. Hendren, and D.R. Thakker Evidence for a polarised efflux system in Caco-2 cells capable of modulating cyclosporin A transport Biochem. Biophys. Res. Commun. 197 1993 360 365
4. J.F. Borel, and Z.L. Kis The discovery and development of cyclosporin (Sandimmune) Transplant Proc. 23 1991 1867 1874
5. M.R. First, R.R. Alloway, R.A. Fisher, S.H. Pan, R. Lopez, D. Renlund, M. Schnitzler, and A.O. Gaber Generic drug substitution in transplantation: Examples from the epic of cyclosporine development Dialysis Transplant. 29 2000 260 267
6. A.J. Humberstone, and W.N. Charman Lipid-based vehicles for the oral delivery of poorly water soluble drugs Adv. Drug Del. Rev. 25 1997 103 128
7. A. Jegorov, P. Halada, and K. šafarčík Cyclosporin A metabolism in brown bullhead, Ameriurus nebulosus Fish Physiol. Biochem. 23 2000 257 264
8. N. Jibry, R. Heenan, and S. Murdan Amphiphilogels for drug delivery: formulation and characterisation Pharm. Res. 21 2004 1852 1861
9. N. Jibry, and S. Murdan Novel amphiphilogels as transdermal delivery vehicles for proteins AAPS PharmSci. 4 2002 R6069
10. B.A. Klyashchitsky, and A.J. Owen Drug delivery systems for cyclosporine: achievements and complications J. Drug Target. 5 1998 443 458
11. M. Lebwohl, C. Ellis, A. Gottlieb, J. Koo, G. Krueger, K. Linden, J. Shupack, and G. Weinstein Cyclosporine consensus conference: with emphasis on the treatment of psoriasis J. Am. Acad. Dermatol. 39 1998 464 475
12. W.K. Lee, J. Lee, W.U. Kim, C.S. Cho, H.Y. Kim, H.J. Ahn, S.H. Han, Y.W. Lee, J. Kim, H.S. Cha, E.M. Koh, C.K. Lee, and S.K. Lee Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. A prospective, multicenter, 40-week study Arthritis Rheum. 44 2001 S1914
13. C.A. Marra, G. Guh, J.H. Fisher, A. Chalmers, J.M. Esdaile, and A.H. Anis The effectiveness of cyclosporine (CyA) in rheumatoid arthritis (RA): a longitudinal analysis of a population-based registry Arthritis Rheum. 43 2000 S402
14. S. Murdan, J. Ford, J. Woolfe, and A.T. Florence Novel 'amphiphilogels' as oral vehicles for cyclosporin A: in vivo studies in dogs AAPS PharmSci. 1999 437
15. M.M. Nerurkar, P.S. Burton, and R.T. Borchardt The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarised efflux system Pharm. Res. 13 1996 528 534
16. C.W. Pouton Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems Eur. J. Pharm. Sci. 11 2000 S93 S98
17. P.Y. Robert, V. Leconte, C. Olive, V. Ratsimbazafy, M. Javerliat, and J.P. Adenis Cyclosporin A eyedrops: manufacturing, kinetics and indications in 2000 J. Franc. D' Ophtalmol. 24 2001 527 535
18. S. Rohatagi, F. Calic, N. Harding, M.L. Ozoux, J.P. Bouriot, S. Kirkesseli, L. DeLeij, and B.K. Jensen Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients J. Clin. Pharmacol. 40 2000 1211 1226
19. K. šafarčík, H. Brozmanová, V. Bartoš, A. Jegorov, and M. Grundmann Evaluation and comparison of therapeutic monitoring of whole-blood levels of cyclosporin A and its metabolites in renal transplantation by HPLC and RIA methods Clin. Chim. Acta. 310 2001 165 171
20. K. Sall, O.D. Stevenson, T.K. Mundorf, and B.L. Reis Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease Ophthalmology 107 2000 631 639
21. W.J. Sandborn A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate Am. J. Gastroenterol. 91 1996 423 433
22. P. Sarzi-Puttini, B. Panni, L. Boccassini, M. Scarpellini, E. D'Ingianna, N. Belay, T. Fiorini, B. Arsizio, C. Balsamo, and C. Balsamo A 12-month, open, randomised, multicentre comparison study of cyclosporine A, cyclosporine A plus methotrexate, cyclosporine A plus hydroxychloquine in the treatment of early severe rheumatoid arthritis Arthritis Rheum. 43 2000 S1895
23. D. Uhrikova, T. Andrýsek, S. Funari, and P. Balgavy Synchrotron radiation small- and wide- angle scattering study of dispergation of Equoral, a novel drug delivery system with cyclosporine A Die Pharmazie 59 2004 650 651
24. J. Vonderscher, and A. Meinzer Rationale for the development of Sandimmune-Neoral Transplant. Proc. 26 1994 2925 2927
25. A. Vrana, and T. Andrýsek The effect of particle size on bioavailability in cyclosporine preparations based on submicron dispersion Biomed. Pap. 145 2001 9 15